Paula J Swain Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 month, 2 weeks ago
Paula J Swain has an estimated net worth of at least $11.6 million*, as of Oct. 29, 2025. They own 106,482 shares of INCY stock. They have sold 28,638 shares of INCY stock since 2021, for an estimated $2.0 million.
Paula J Swain $INCY SEC Form 4 Insider Trading
Paula J Swain has filed a total of 3 insider trades in $INCY since 2021. Their most recent trade was a sale of 8,449 shares, made on Sep 01, 2023. Their largest trade was a sale of 10,870 shares, made on Jan 07, 2022. We estimate that they now own 106,482 shares of $INCY, worth an estimated $9.6 million.
Insider Trading at $INCY
There have been a total of 125 insider trades reported at $INCY since 2021, with 4.1 million shares purchased and 688,963 shares sold. The most active insider traders in $INCY stock have been Sheila A. Denton, Vijay K Iyengar, and Barry P Flannelly. The most recent trade was a sale of 5,553 shares reported by Patrick A Mayes (EVP & Chief Scientific Officer), made on Dec 10, 2025.
History of Insider Stock Trades by Paula J Swain
$INCY Executives and Stock Owners with Insider Trades
-
Sheila A. Denton, EVP & General Counsel
-
Vijay K Iyengar, EVP, GMAPPS
-
Barry P Flannelly, EVP & General Manager US
-
Steven H Stein, EVP & Chief Medical Officer
-
Thomas Tray, Principal Accounting Officer
-
Maria E Pasquale, EVP & General Counsel
-
Dashyant Dhanak, EVP & Chief Scientific Officer
-
Jonathan Elliott Dickinson, EVP, General Manager, Europe
-
Paula J Swain, EVP, Human Resources
-
Patrick A Mayes, EVP & Chief Scientific Officer
-
Paul Trower, Principal Accounting Officer
-
Lee Heeson, EVP, Head of Incyte Intl
-
Vijay K Iyengar, EVP GPS, BD, & Licensing
-
Yao Wenqing, EVP, Head of Discovery Chem
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.